Human Investing LLC Biogen Inc. Transaction History

Human Investing LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$242.95 - $284.63 $102,039 - $119,544	-420 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $2,362 - $3,556	-10 Reduced 2.33%	420 $103,000
Q1 2020 Apr 22, 2020	SELL	$268.85 - $341.04 $67,750 - $85,942	-252 Reduced 36.95%	430 $136,000
Q3 2019 Nov 07, 2019	BUY	$217.44 - $243.88 $53,707 - $60,238	247 Added 56.78%	682 $159,000
Q2 2019 Aug 16, 2019	BUY	$219.29 - $241.72 $19,516 - $21,513	89 Added 25.72%	435 $102,000
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $2,383 - $3,728	11 Added 3.28%	346 $82,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $93,297 - $118,171	335 New	335 $101,000

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

Stay updated on Human Investing LLC with notifications on news.